Virulence Genetics of Cf Associated B Cepacia

Goldstein, Richard

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
• Type: Research Project (R01)
• Project #: 3R01DK050838-01S1
• Application #: 2151918
• Study Section: Bacteriology and Mycology Subcommittee 2 (BM)
• Project Start: 1995-06-01
• Project End: 1999-05-31
• Budget Start: 1995-07-01
• Budget End: 1996-05-31
• Support Year: 1
• Fiscal Year: 1995

Institution

• Name: Boston Health and Hospitals Department
• City: Boston
• State: MA
• Country: United States
• Zip Code: 02118

Publications

Bolduc, G R; Bouchet, V; Jiang, R Z et al. (2000) Variability of outer membrane protein P1 and its evaluation as a vaccine candidate against experimental otitis media due to nontypeable Haemophilus influenzae: an unambiguous, multifaceted approach. Infect Immun 68:4505-17

Holmes, A; Nolan, R; Taylor, R et al. (1999) An epidemic of burkholderia cepacia transmitted between patients with and without cystic fibrosis. J Infect Dis 179:1197-205

Sharma, S A; Tummuru, M K; Blaser, M J et al. (1998) Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-kappa B in gastric epithelial cells. J Immunol 160:2401-7

Holmes, A; Govan, J; Goldstein, R (1998) Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health? Emerg Infect Dis 4:221-7

Sun, L; Jiang, R Z; Steinbach, S et al. (1995) The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nat Med 1:661-6